---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-021242"
form_type: "8-K"
ticker: "MOVE"
cik: "0001734750"
company_name: "Corvex, Inc."
filed_at: "2023-03-20T23:59:59+00:00"
generated_at: "2026-06-17T23:01:38.158692+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Movano Health Q4 2022 net loss $7.9M; progressing toward summer 2023 Evie Ring launch

## Summary
- Net loss of $7.9M ($0.24/sh) in Q4 2022 vs $6.3M ($0.19/sh) in Q4 2021; no revenue in either period.
- Cash and equivalents $10.8M at Dec 31, 2022; completed $7.5M public offering in Q1 2023.
- Evie Ring on track for summer 2023 launch; second beta program with global athletic apparel and medical device firms.
- Plan to file first 510(k) for heart rate and SpO2 clearance this spring after successful hypoxia trial (2% SpO2 margin of error).
- Issued 9 new U.S. patents (21 total) for non-invasive blood pressure and glucose monitoring; first clinical studies imminent.

## SEC filing metadata
- accession: 0001213900-23-021242
- form_type: 8-K
- ticker: MOVE
- cik: 0001734750
- company_name: Corvex, Inc.
- filed_at: 2023-03-20T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1734750/000121390023021242/0001213900-23-021242-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1734750/000121390023021242/ea175393-8k_movanoinc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-021242
- JSON: https://secwatch.observer/filing/0001213900-23-021242.json
- Plain text: https://secwatch.observer/filing/0001213900-23-021242.txt

## Key facts
- Earnings Releases
  Corvex, Inc. reported the three months and year ending December 31, 2022 results: net income a net loss attributable to common stockholders of $7.9 million, or a loss of $(0.24) per basic and diluted share, in the, EPS net loss attributable to common stockholders of $30.3 million or $(0.92) per share, compared with a net loss attributabl.
  - Period: the three months and year ending December 31, 2022
  - Net income: a net loss attributable to common stockholders of $7.9 million, or a loss of $(0.24) per basic and diluted share, in the
  - EPS: net loss attributable to common stockholders of $30.3 million or $(0.92) per share, compared with a net loss attributabl
  - Result: reported results
  source text: On March 20, 2023, Movano Inc. announced its financial results for the quarter and year ended December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1734750/000121390023021242/0001213900-23-021242-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.